ODM-201
CAS No. 1297538-32-9
ODM-201 ( BAY-1841788;Darolutamide )
Catalog No. M11201 CAS No. 1297538-32-9
A potent wt/mutant androgen receptor (AR) inhibitor with Ki of 11 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 58 | In Stock |
|
5MG | 96 | In Stock |
|
10MG | 152 | In Stock |
|
25MG | 251 | In Stock |
|
50MG | 357 | In Stock |
|
100MG | 531 | In Stock |
|
500MG | 1152 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameODM-201
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent wt/mutant androgen receptor (AR) inhibitor with Ki of 11 nM.
-
DescriptionA potent wt/mutant androgen receptor (AR) inhibitor with Ki of 11 nM; inhibits wtAR/AR(F876L) with IC50 of 65/66 nM respectively, weak inhibition on AR(W741L) and AR(T877A); inhibits the nuclear translocation of AR and more efficaciously than enzalutamide or ARN-509 in VCaP cell line proliferation assay; reduces the growth of AR-overexpressing VCaP prostate cancer cells both in vitro and in a castration-resistant VCaP xenograft model.Prostate Cancer Phase 3 Clinical
-
SynonymsBAY-1841788;Darolutamide
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogenReceptor
-
Research AreaCancer
-
IndicationProstate Cancer
Chemical Information
-
CAS Number1297538-32-9
-
Formula Weight398.85
-
Molecular FormulaC19H19ClN6O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 44 mg/mL
-
SMILESO=C(C1=NNC(C(O)C)=C1)N[C@@H](C)CN2N=C(C3=CC=C(C#N)C(Cl)=C3)C=C2
-
Chemical Name1H-Pyrazole-3-carboxamide, N-[(1S)-2-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-5-(1-hydroxyethyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Moilanen AM, et al. Sci Rep. 2015 Jul 3;5:12007.
2. Fizazi K, et al. Lancet Oncol. 2014 Aug;15(9):975-85.
3. Cancer Discov. 2014 Sep;4(9):OF10.
2. Fizazi K, et al. Lancet Oncol. 2014 Aug;15(9):975-85.
3. Cancer Discov. 2014 Sep;4(9):OF10.
molnova catalog
related products
-
EPI-001
EPI-001 is a small molecule that blocks transactivation of the androgen Receptor (AR) NTD (IC50=6 uM).
-
JNJ63576253
JNJ-63576253 is a Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC).
-
MK-0773
A potent, selective androgen receptor modulator (SARM) with binding IC50 of 6.6 nM.